How best to use new therapies in multiple myeloma
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference108 articles.
1. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008
2. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring;Golub;Science,1999
3. Molecular pathogenesis and a consequent classification of multiple myeloma;Bergsagel;J Clin Oncol,2005
4. Multiple myeloma: evolving genetic events and host interactions;Kuehl;Nat Rev Cancer,2002
5. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets;Hideshima;Nat Rev Cancer,2007
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current status of drug development for patients with multiple myeloma: a review of comparison in China and the rest of world;Antibody Therapeutics;2023-04
2. How is patient care for multiple myeloma advancing?;Expert Review of Hematology;2017-05-19
3. Patient, physician and contextual factors are influential in the treatment decision making of older adults newly diagnosed with symptomatic myeloma;Cancer Treatment Communications;2014
4. Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma;Experimental Hematology & Oncology;2012-11-26
5. 8-Chloroadenosine 3′,5′-monophosphate induces cell cycle arrest and apoptosis in multiple myeloma cells through multiple mechanisms;Oncology Letters;2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3